Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimates he has made of the additional resources needed and the cost of providing additional dialysis capacity for those patients who will no longer be suitable for a kidney transplant and for those patients whose transplant graft fails due as a result of restrictions in the range of immunosuppressant agents that will be introduced if the recommendations of the NICE review of TA 85 [ID456] are upheld at appeal.

We have made no such assessment.

The National Institute for Health and Care Excellence (NICE) has not yet published its final updated guidance on the use of immunosuppressive therapy for kidney transplant in adults (review of TA85) or on the use of immunosuppressive therapy for kidney transplant in children and young people (review of TA99). NICE is developing resource impact reports to support implementation of its guidance which will be published alongside its final technology appraisal guidance.